• Loading stock data...
Est. 2004

Thursday 03/7/2019

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

engineered soils

  • 10:05 AM

    PALM BEACH, FL–QPWR, (Marketwired – Jul 25, 2017) – Q2Power Technologies Inc. (d/b/a Q2Earth or Q2) (OTCQB: QPWR) announced that it has successfully completed a Phase I services contract for Fordstam Limited, the owner of the Chelsea Football Club, United Kingdom. The project included delivery of a feasibility report demonstrating positive results for the beneficial reuse of aggregate materials to be excavated from the team’s proposed new stadium construction. As a result of the Phase I conclusions, Q2Earth has been awarded a

    Read more
  • 9:12 PM

    ROSELAND, N.J., Feb 20, 2015 (GLOBE NEWSWIRE via COMTEX) — Emisphere Technologies, Inc. (OTCBB:EMIS) today highlighted positive Phase 2 data from Eligen(R) licensee Novo Nordisk pertaining to OG217SC, the oral formulation of semaglutide, a long-acting human GLP-1 analogue that stimulates insulin and suppresses glucagon secretion in a glucose-dependent manner. OG217SC is provided in a tablet formulation with an absorption-enhancing excipient, SNAC. SNAC is included in the Eligen(R) Carrier Concept. Novo Nordisk today announced that it has successfully completed the phase

    Read more
  • 2:36 PM

    ROSELAND, N.J., Aug 20, 2014 (GLOBE NEWSWIRE via COMTEX) — Emisphere Technologies, Inc. (OTCBB:EMIS) (“Emisphere” or the “Company”) today announced that it has reached agreement with MHR Fund Management LLC, and certain of its affiliated funds (“MHR”), to finance the upcoming launch of the Company’s first commercial prescription product, oral Eligen B12 in the United States through a new loan facility, and to amend the terms of the Company’s existing obligations under various promissory notes previously issued to MHR to

    Read more
Public Wire Banner